Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Intercept Pharmaceuticals, Inc. (ICPT)

13.67   0.67 (5.15%) 06-29 17:15
Open: 13.02 Pre. Close: 13
High: 13.7 Low: 12.86
Volume: 349,804 Market Cap: 406(M)
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.71 - 13.77 13.77 - 13.84
Low: 12.71 - 12.77 12.77 - 12.84
Close: 13.56 - 13.67 13.67 - 13.78

Technical analysis

as of: 2022-06-29 4:54:44 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 18.41     One year: 21.99
Support: Support1: 10.81    Support2: 8.99
Resistance: Resistance1: 15.76    Resistance2: 18.82
Pivot: 12.62
Moving Average: MA(5): 13.44     MA(20): 13.32
MA(100): 15.79     MA(250): 16.08
MACD: MACD(12,26): -0.9     Signal(9): -1.1
Stochastic oscillator: %K(14,3): 71.2     %D(3): 59.8
RSI: RSI(14): 46.6
52-week: High: 20.5  Low: 10.81
Average Vol(K): 3-Month: 964 (K)  10-Days: 672 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ICPT ] has closed below upper band by 15.4%. Bollinger Bands are 21.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 29 Jun 2022
Why did Arrowhead Pharmaceuticals stock pop up today? - Seeking Alpha

Wed, 29 Jun 2022
Impact Clean Power Technology builds plant in Poland - electrive.com - www.electrive.com

Wed, 29 Jun 2022
R&D Efforts for Central Nervous System (CNS) Therapeutics Have Resulted in Hopeful Novel Drug-Delivery Solutions - Digital Journal

Tue, 28 Jun 2022
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Tue, 28 Jun 2022
TNB should diversify gas, coal sources, say analysts - Free Malaysia Today

Mon, 27 Jun 2022
ICPT concerns may resurface given the high coal prices - The Star Online

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 30 (M)
Shares Float 25 (M)
% Held by Insiders 4.3 (%)
% Held by Institutions 101.5 (%)
Shares Short 7,990 (K)
Shares Short P.Month 8,240 (K)

Stock Financials

EPS -3.28
EPS Est Next Qtl -3.45
EPS Est This Year -13.99
EPS Est Next Year -11.6
Book Value (p.s.) -5.29
Profit Margin (%) -25.2
Operating Margin (%) -15.4
Return on Assets (ttm) -6.3
Return on Equity (ttm) 0
Qtrly Rev. Growth 11
Gross Profit (p.s.) 12.19
Sales Per Share 12.3
EBITDA (p.s.) -1.79
Qtrly Earnings Growth 0
Operating Cash Flow -42 (M)
Levered Free Cash Flow -14 (M)

Stock Valuations

PE Ratio -4.17
PEG Ratio -3.8
Price to Book value -2.59
Price to Sales 1.11
Price to Cash Flow -9.71

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.